Pharming Group N.V Ratios (2019-2025) | PHAR

Ratios Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 89.51%88.44%88.88%90.65%88.63%89.31%89.54%91.97%95.61%90.80%90.50%89.51%87.56%91.24%84.91%89.23%90.89%86.82%92.73%
EBT Margin -56.07%9.99%0.03%40.29%-37.84%24.24%9.08%39.00%14.31%24.59%-32.20%-13.78%2.86%-5.65%-29.35%-22.59%5.49%-6.39%-392.67%92.73%
EBIT Margin 40.84%30.84%14.42%21.88%-3.44%-3.36%6.06%35.54%14.31%21.34%-32.20%-15.24%2.86%-6.63%-29.35%-26.23%5.49%-9.30%-392.67%92.73%
EBITDA Margin 40.84%30.84%14.42%21.88%-3.44%-3.36%6.06%35.54%14.31%21.34%-32.20%-15.24%2.86%-6.63%-29.35%-26.23%5.49%-9.30%-392.67%92.73%
Operating Margin 40.84%30.84%14.42%21.88%-3.44%-3.36%6.06%35.54%14.31%21.34%-32.20%-15.24%2.86%-6.63%-29.35%-26.23%5.49%-9.30%-392.67%92.73%
Net Margin -55.17%33.72%0.04%28.89%-48.55%27.20%10.74%46.61%14.64%19.85%-42.78%-19.84%2.63%-13.41%0.00%0.00%0.00%-3.68%0.00%0.00%
FCF Margin 32.58%25.06%0.02%43.98%-41.28%17.09%1.75%9.01%-9.80%0.84%
Efficiency
Inventory Average 6.99M-1.44M-0.31M-1.56M-1.58M-1.23M13.58M11.49M-3.31M-0.99M21.36M55.12M56.34M58.98M57.53M61.53M65.43M
Assets Average 0.41M206.13M206.13M198.86M395.06M393.35M388.11M404.06M424.40M426.40M433.14M449.66M452.26M428.80M420.72M412.75M401.58M424.72M460.02M
Equity Average 0.18M99.13M197.42M194.84M193.47M196.85M99.94M102.42M201.99M199.86M205.16M214.36M212.36M213.44M223.36M223.43M217.53M226.77M252.10M
Invested Capital 117.68M0.36M0.28M198.14M196.82M193.08M194.18M199.82M0.34M204.64M199.34M200.37M209.94M218.78M205.94M220.94M225.79M221.06M214.00M239.55M264.64M
Asset Utilization Ratio 1.011.001.000.510.510.530.610.570.580.600.550.570.650.680.720.570.57
Leverage & Solvency
Debt to Equity 0.34141.561.010.000.000.000.000.000.71
Debt Ratio 0.1562.060.460.000.960.000.000.000.00
Equity Ratio 0.460.440.460.48482.730.490.490.510.000.480.470.470.480.470.470.530.530.550.530.540.56
Valuation
Enterprise Value -76.89M-181.99M763.40M553.22M531.62M352.92M570.10M383.83M378.42M638.37M774.05M701.29M718.54M750.00M751.91M674.05M516.09M558.09M681.26M568.87M724.21M984.12M
Market Capitalization 969.53M760.84M719.95M536.28M571.11M574.30M568.30M638.37M775.15M886.07M823.97M751.46M753.44M727.44M517.58M559.64M682.76M569.16M727.25M986.45M
Return Ratios
Return on Sales -0.07%-0.05%0.03%0.05%0.04%0.21%0.26%0.17%0.03%0.01%-0.13%-0.13%-0.16%-0.14%-0.12%-0.03%0.39%
Return on Capital Employed 0.36%0.21%0.09%0.03%0.05%0.07%0.14%0.09%0.02%0.00%-0.07%-0.11%-0.11%-0.11%-0.12%-0.06%0.24%
Return on Invested Capital 0.03%0.03%0.04%0.25%0.03%0.00%-0.04%
Return on Assets -0.07%-0.05%0.03%0.03%0.02%0.11%0.16%0.10%0.02%0.00%-0.07%-0.08%-0.10%-0.09%-0.09%-0.02%0.22%
Return on Equity -0.14%-0.05%0.03%0.06%0.04%0.42%0.63%0.21%0.04%0.01%-0.15%-0.16%-0.21%-0.18%-0.17%-0.03%0.41%